Non-invasive evaluation of liver fibrosis: More well-validated tests available for patient management

Liver International

Volumn 35, Issue 6, 2015, Pages 1643-1645

  Guéchot, Jérôme ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALCOHOL LIVER DISEASE; ALGORITHM; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CHRONIC LIVER DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EDITORIAL; ELASTOGRAPH; ELASTOGRAPHY; ENHANCED LIVER FIBROSIS SCORE; HUMAN; IMMUNOASSAY; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST KIT; LIVER HISTOLOGY; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; ORIGINAL EUROPEAN LIVER FIBROSIS SCORE; PATIENT CARE; PRIMARY BILIARY CIRRHOSIS; REIMBURSEMENT; SCORING SYSTEM; STAGING; TRANSIENT ELASTOGRAPHY; BLOOD; FEMALE; LIVER; LIVER CIRRHOSIS; MALE; PATHOLOGY;

BIOMARKERS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84929085844     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12790     Document Type: Editorial

References (20)

1. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus Infection. A systematic review. Ann Intern Med 2013; 158: 807-20.
2. Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 2013; 33: 1138-47.
3. Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-13.
4. Parkes J, Guha IN, Roderick P, et al. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat 2011; 18: 23-31.
5. Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP, and the ANRS HCEP 23 FIBROSTAR Group. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C. Clin Chem Lab Med 2012; 50: 693-9.
6. Fagan K, Pretorius C, Horsfall LU, et al. ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. Liver Int 2015; 35: 1673-81.
7. Xie Q, Zhou X, Huang P, et al. The performance of enhanced liver fibrosis (ELF) test for staging of liver fibrosis: a meta-analysis. PlosOne 2014; 9: e97772.
8. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
9. Mehta S, Lau B, Afdhal N, Thomas D. Exceeding the limits of liver histology markers. J Hepatol 2009; 50: 36-41.
10. Zarski JP, Sturm N, Guéchot J, et al. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS ONE 2013; 8: e59088.
11. Boursier J, de Ledinghen V, Sturm N, et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J Gastroenterol 2014; 49: 527-37.
12. Imbert-Bismuth F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.
13. Calès P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-81.
14. Adams LA, Bulsara M, Rossi E, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 1867-73.
15. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
16. Friedrich-Rust M, Rosenberg W, Parkes J, et al. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010; 10: 103.
17. Zarski JP, Sturm N, Guéchot J, et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012; 56: 55-62.
18. Haute Autorité de Santé Méthodes non invasives de mesure de la fibrose/cirrhose hépatique - Avis sur les actes. 2008 Available at: http://www.has-sante.fr (accessed January 2015).
19. Mayo MJ, Parkes J, Adams-Huet B, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology 2008; 48: 1549-57.
20. Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010; 59: 1245-51.